Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease-Reference-Cited by-同舟云学术

Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease

Published:2004-09 Issue:6 Volume:20 Page:607-614
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Franchimont N.,Putzeys V.,Collette J.,Vermeire S.,Rutgeerts P.,De Vos M.,Van Gossum A.,Franchimont D.,Fiasse R.,Pelckmans P.,Malaise M.,Belaiche J.,Louis E.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2004.02152.x/fullpdf

Reference55 articles.

1. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis;Ghosh;Gastroenterology,1994

2. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis;Bernstein;J Bone Miner Res,1995

3. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study;Jahnsen;Gut,1997

4. Bone mineral density assessment in children with inflammatory bowel disease;Gokhale;Gastroenterology,1998

5. Osteoporosis and determinants of bone density in patients with Crohn's disease;Robinson;Dig Dis Sci,1998

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Intersection: Sarcopenia and Sarcopenic Obesity in Inflammatory Bowel Disease;Biomedicines;2024-05-30

2. Signaling pathways associated with bone loss in inflammatory bowel disease;Annals of Gastroenterology;2023

3. Biomarkers of Bone Remodeling;Clinical and Laboratory Medicine Textbook;2023

4. Bone Fragility in Gastrointestinal Disorders;International Journal of Molecular Sciences;2022-02-28

5. Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease;PLOS ONE;2021-04-27